Healthcare >> Analyst Interviews >> June 2, 2002

Biotechnology: Industry Overview: Carolyn Pratt – Needham & Co

Carolyn Pratt, a Biotech Analyst at Needham & Company, joined the company in 1999 to cover biotechnology and life sciences. She previously worked in the Biotechnology Equity Research Group at Montgomery Securities, now Banc of America Securities. From 1987 to 1997, she worked at Genetics Institute, Inc., now part of American Home Products. Prior to Genetics Institute, from 1982 to 1997, she worked at Ortho Pharmaceutical Corporation and Ortho Biotech, both divisions of Johnson & Johnson. She has a degree in Pharmacy. Profile
TWST: Carolyn, will you begin by telling us about the approach that you

take to investing in biotechnology, and the characteristics of the

companies that you focus on most closely?

Ms. Pratt: